Literature DB >> 1907838

Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver.

A Temellini1, L Giuliani, G M Pacifici.   

Abstract

1. Glucuronidation and sulphation of ethinyloestradiol (EE2) was studied in human liver. Microsomal glucuronyltransferase activity was measured in 110 livers whose donors were 71 women and 39 men. Enzyme activity ranged between 12.6 and 242 pmol min-1 mg-1 protein, i.e. over a 19-fold range and the mean (+/- s.d.) glucuronyltransferase activity was 96.8 +/- 47.9 pmol min-1 mg-1 protein. 2. Cytosolic sulphotransferase activity was measured in 138 livers whose donors were 90 women and 48 men. Enzyme activity ranged between 14.4 and 98.2 pmol min-1 mg-1 protein, i.e. over a 7-fold range, and the mean (+/- s.d.) sulphotransferase activity was 43.7 +/- 18.6 pmol min-1 mg-1 protein. 3. Human liver glucuronyltransferase and sulphotransferase activities showed a unimodal distribution pattern. Enzyme activities were neither sex-related nor age-dependent. Sulphotransferase activity did not correlate with glucuronyltransferase activity (n = 80) suggesting that the two enzymes are independently regulated. The ratio of specific glucuronyltransferase to sulphotransferase activity ranged between 0.15 and 8.0 (mean +/- s.d., 2.44 +/- 1.51) and was unimodally distributed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907838      PMCID: PMC1368576          DOI: 10.1111/j.1365-2125.1991.tb05589.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

Review 1.  N-acetyltransferase.

Authors:  D A Evans
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  The parasympathetic neuroeffector junction of the heart.

Authors:  K Löffelholz; A J Pappano
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

4.  Foreign compound metabolism studies with human liver obtained as surgical waste. Relation to donor characteristics and effects of tissue storage.

Authors:  G Powis; I Jardine; R Van Dyke; R Weinshilboum; D Moore; T Wilke; W Rhodes; R Nelson; L Benson; C Szumlanski
Journal:  Drug Metab Dispos       Date:  1988 Jul-Aug       Impact factor: 3.922

5.  Human urinary and liver conjugates of 17alpha-ethnylestradiol.

Authors:  E D Helton; M C Williams; J W Goldzieher
Journal:  Steroids       Date:  1976-06       Impact factor: 2.668

Review 6.  Interindividual variation in the metabolism of ethynylestradiol.

Authors:  M L Orme; D J Back; S Ball
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 7.  Methyltransferase pharmacogenetics.

Authors:  R Weinshilboum
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

8.  Human brain sulphotransferase and glucuronyltransferase.

Authors:  A Viani; A Temellini; G Tusini; G M Pacifici
Journal:  Hum Exp Toxicol       Date:  1990-03       Impact factor: 2.903

9.  Sulphation and glucuronidation of ethinyloestradiol in human liver in vitro.

Authors:  G M Pacifici; D J Back
Journal:  J Steroid Biochem       Date:  1988-09       Impact factor: 4.292

  9 in total
  12 in total

1.  Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes.

Authors:  A P Li; N R Hartman; C Lu; J M Collins; J M Strong
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.

Authors:  D Ouellet; A Hsu; J Qian; C S Locke; C J Eason; J H Cavanaugh; J M Leonard; G R Granneman
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 3.  Age-related changes in the gastrointestinal system. Effects on drug therapy.

Authors:  F L Iber; P A Murphy; E S Connor
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

4.  Stereoselective glucuronidation of formoterol by human liver microsomes.

Authors:  M Zhang; J P Fawcett; J M Kennedy; J P Shaw
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

5.  Testosterone sulphation and glucuronidation in the human liver: interindividual variability.

Authors:  G M Pacifici; A Gucci; L Giuliani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

6.  Minoxidil sulphation in human liver and platelets. A study of interindividual variability.

Authors:  G M Pacifici; R Bigotti; G Marchi; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Interindividual variability in the N-sulphation of desipramine in human liver and platelets.

Authors:  P Romiti; L Giuliani; G M Pacifici
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

8.  Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.

Authors:  M Barry; J L Howe; D J Back; A M Swart; A M Breckenridge; I V Weller; N Beeching; F Nye
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

9.  Interindividual variability of phenol- and catechol-sulphotransferases in platelets from adults and newborns.

Authors:  G M Pacifici; G Marchi
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

10.  Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase.

Authors:  G M Pacifici; M A Ferroni; A Temellini; A Gucci; M C Morelli; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.